Download | < Back |
15 Jun 2018 | |
This is to inform the exchange that the Company has received Establishment Inspection Report (EIR) from United States Food and Drug Administration (US FDA) for the inspection carried out by them at our Formulation Facility at Panelav during the period from 12th March, 2018 to 20th March, 2018. <BR> <BR> We request you to kindly take the same on record.<BR> | |
View all announcements for ALEMBIC PHARMACEUTICALS LTD. | Source: BSE India |